Valuation: Jenburkt Pharmaceuticals Limited

Market Cap 3.77B 39.69M 35.55M 32.7M 29.63M 55.38M 56.42M 390M 157M 1.98B 149M 146M 6.25B P/E 2025
13.9x
P/E 2026 12.1x
Enterprise Value 3.32B 34.97M 31.32M 28.81M 26.1M 48.8M 49.71M 344M 138M 1.75B 131M 128M 5.51B EV / Sales 2025
2.82x
EV / Sales 2026 2.23x
Free-Float
38.82%
Yield 2025
1.78%
Yield 2026 2.17%
1 day-1.39%
1 week-2.62%
Current month-6.94%
1 month-9.07%
3 months-19.43%
6 months-18.46%
Current year-21.64%
1 week 848.35
Extreme 848.35
895
1 month 848.35
Extreme 848.35
1,045
Current year 848.35
Extreme 848.35
1,245
1 year 848.35
Extreme 848.35
1,321
3 years 586.9
Extreme 586.9
1,410
5 years 452.1
Extreme 452.1
1,410
10 years 243.2
Extreme 243.2
1,410
Manager TitleAgeSince
Chief Executive Officer - 2013-10-21
Director of Finance/CFO 74 2013-09-23
Chief Administrative Officer - 2025-05-11
Director TitleAgeSince
Chairman - 2013-10-21
Director/Board Member 74 2013-09-06
Director/Board Member 63 2020-03-27
Change 5-day change 1-year change 3-year change Capi.($)
-1.39%-2.62%-25.85%+35.14% 40.13M
+3.19%+8.48%+74.25%+153.03% 1,224B
-0.73%+2.09%+46.41%+87.64% 662B
+1.41%+3.40%+30.98%+112.26% 514B
+0.42%+2.88%+54.92%+69.67% 388B
+2.18%+1.55%+72.70%+45.42% 361B
+1.12%+3.80%+35.82%+59.72% 302B
+6.96%+7.55%+11.15%+37.89% 271B
+1.15%+4.19%+59.72%+78.16% 249B
+3.06%+8.58%+44.03%+122.76% 205B
Average +1.42%+2.21%+40.41%+80.17% 417.69B
Weighted average by Cap. +1.17%+3.04%+53.35%+100.42%

Financials

2025 2026
Net sales 1.52B 15.98M 14.31M 13.16M 11.92M 22.29M 22.71M 157M 63M 798M 59.96M 58.68M 2.52B 1.69B 17.77M 15.92M 14.64M 13.27M 24.8M 25.26M 175M 70.09M 888M 66.69M 65.28M 2.8B
Net income 321M 3.38M 3.02M 2.78M 2.52M 4.71M 4.8M 33.17M 13.32M 169M 12.67M 12.4M 532M 347M 3.66M 3.28M 3.01M 2.73M 5.1M 5.2M 35.94M 14.43M 183M 13.73M 13.44M 576M
Net Debt -192M -2.03M -1.82M -1.67M -1.51M -2.83M -2.88M -19.92M -8M -101M -7.61M -7.45M -319M -448M -4.72M -4.23M -3.89M -3.52M -6.59M -6.71M -46.38M -18.62M -236M -17.72M -17.34M -744M
Projected Income Statement - Annual - Jenburkt Pharmaceuticals Limited
Logo Jenburkt Pharmaceuticals Limited
Jenburkt Pharmaceuticals Limited is an India-based company that is engaged in the business of manufacturing, producing, developing and marketing a range of branded pharmaceuticals and healthcare products. The Company offers pharmaceutical products for various therapeutic areas, including analgesic and antipyretics, anthelmintics, anti-arthritics, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants/antacids, aphrodisiac, consumer products, muscle relaxants, neuropathic pain, nutraceuticals, and pain management. The Company's product brands include Allerzine tablets, Cartisafe forte MSM tablets, Eberjen Cream and SOL, ECOPROT powder, Frendacid suspension, Fundu tablets, Glajen-E capsules, GLUCOTROL tablets, Jenflam tablets, Lutriben cream, Ornel tablets, Pantazole tablets, Topcal-M Tablets, Powergesic, ZIX P Tablet, and others. The Company's manufacturing plant is in Sihor, Gujarat.
Employees
801
Date Price Change Volume
26-10-30 ₹854.00 -1.39% 86
26-10-29 ₹866.00 -3.01% 1,120
26-10-27 ₹892.90 +2.51% 76
26-10-26 ₹871.05 +1.28% 194
26-10-23 ₹860.00 -1.93% 53
  1. Stock Market
  2. Stocks
  3. JENBURPH Stock